WHO ICTRP trial
To determine whether Flexsure is safe, tolerable and effective in relieving…
CTRI/2011/07/001911 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2011/07/001911 |
|---|---|
| Public title | To determine whether Flexsure is safe, tolerable and effective in relieving symptoms of moderate osteoarthritis of the knee. |
| Scientific title | A randomized double-blind placebo-controlled study to determine whether Flexsure is safe, tolerable and effective in relieving symptoms of moderate osteoarthritis of the knee. - None |
| Primary sponsor | Vital gNetics |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: null- Osteoarthritis |
| Interventions | Intervention1: Flexsure Capsules: Ingredients: Uncaria tomentosa Boswellia serrata Lepidium meyenii L-Leucine Dosage: 3 capsules to be consumed empty stomach once a day for 56 days Control Intervention1: Placebo Capsules: Ingredients… |
| Registration date | Jul 25, 2011 |
| Target size | 60 |
| Secondary IDs | SA/110114/FLX/OA |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: